PERSISTENCE AND CONCOMITANT DRUG USE ON BRANDED DESVENLAFAXINE COMPARED WITH OTHER ANTIDEPRESSANTS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

被引：0
|
作者：
Shelbaya, A. [1 ]
Deshpande, C. [2 ]
Pappadopulos, E. [3 ]
Alvir, J. [3 ]
Chirikov, V [2 ]
Stephens, J. M. [2 ]
机构：
[1] Columbia Univ, Mailman Sch Publ Hlth, Pfizer Inc, New York, NY USA
[2] Pharmerit Int, Bethesda, MD USA
[3] Pfizer Inc, New York, NY USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1366
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH81
引用
收藏
页码：A196 / A196
页数：1
相关论文
共 50 条
  • [1] Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder
    Liu, Xianchen
    Chen, Yi
    Faries, Douglas E.
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2011, 3 : 63 - 72
  • [2] Efficacy of desvenlafaxine compared with placebo in patients with major depressive disorder: A pooled anlaysis
    Thase, M.
    Kornstein, S. G.
    Tummala, R.
    Germain, J. M.
    Jiang, Q.
    Ninan, P. T.
    Guico-Pabia, C.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 200 - 200
  • [3] An Integrated Analysis of the Efficacy of Desvenlafaxine Compared with Placebo in Patients with Major Depressive Disorder
    Thase, Michael E.
    Kornstein, Susan G.
    Germain, Jean-Michel
    Jiang, Qin
    Guico-Pabia, Christine
    Ninan, Philip T.
    [J]. CNS SPECTRUMS, 2009, 14 (03) : 144 - 154
  • [4] ADHERENCE AND PERSISTENCE WITH MEDICATION THERAPY IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A REAL-WORLD COMPARISON OF BRANDED ANTIDEPRESSANTS AND GENERIC SSRIS
    Chen, Y.
    Liu, X.
    Faries, D.
    Watson, P. R.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A115 - A116
  • [5] Use of antidepressants in patients diagnosed with major depressive disorder and adjustment disorder
    Vázquez, MJM
    Aguirre, I
    Salvá, J
    Molina, R
    Toro, MG
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S429 - S430
  • [6] ECONOMIC EVALUATION OF THE USE OF DESVENLAFAXINE IN MAJOR DEPRESSIVE DISORDER IN COLOMBIA
    Vargas-Valencia, J. J.
    Mould-Quevedo, J. F.
    Gutierrez-Ardila, M., V
    Vargas Zea, N.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A61 - A61
  • [7] Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use Disorder
    Kotzalidis, Georgios D.
    Lombardozzi, Ginevra
    Matrone, Marta
    Amici, Emanuela
    Perrini, Filippo
    Cuomo, Ilaria
    De Filippis, Sergio
    [J]. CURRENT NEUROPHARMACOLOGY, 2021, 19 (12) : 2296 - 2307
  • [8] Analysis of Depressive Symptoms in Patients With Major Depressive Disorder Treated With Desvenlafaxine or Placebo
    Kornstein, Susan G.
    Fava, Maurizio
    Jiang, Qin
    Tourian, Karen A.
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 2009, 42 (03) : 21 - 35
  • [9] Efficacy of Desvenlafaxine Compared With Placebo in Major Depressive Disorder Patients by Age Group and Severity of Depression at Baseline
    Mosca, Daniel
    Zhang, Min
    Prieto, Rita
    Boucher, Matthieu
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (02) : 182 - 192
  • [10] Efficacy of desvenlafaxine compared with placebo in major depressive disorder patients by age group and severity of depression at baseline
    Prieto, R.
    Mosca, D.
    Zhang, M.
    Boucher, M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S456 - S456
12345